McKesson (MCK) Stock Price, News & Analysis

Company Overview

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers. McKesson also offers a range of technology and automation solutions — including pharmacy automation, supply chain management software, and analytics — designed to improve operational efficiency, inventory control and patient safety for its customers. In addition, the firm provides support services such as clinical program management, patient access and adherence services for specialty therapies, and commercial services for biopharma manufacturers.

McKesson serves a broad customer base that includes retail and independent pharmacies, long-term care providers, hospitals and health systems, physician offices and specialty clinics. While its operations are concentrated in the United States and Canada, the company works with global pharmaceutical manufacturers and participates in international supply chain activities. Its business model emphasizes integration between distribution, technology and services to support the delivery of medications and related care.

Led by a corporate management team focused on resilience and technology-enabled solutions, McKesson has leveraged its long history in healthcare distribution to prioritize supply chain reliability, digital transformation and expanded services for specialty and complex therapies. The company’s combination of logistics capabilities, service offerings and health-technology products positions it as a key intermediary in the U.S. healthcare system.

Key Stats

• Today's Range: $742.01 to $777.00
• 50-Day Range: $800.99 to $995.05
• 52-Week Range: $637.00 to $999.00
• Volume: 543,736 shs
• Average Volume: 759,891 shs
• Market Capitalization: $92.10 billion
• P/E Ratio: 21.62
• Dividend Yield: 0.44%
• Price Target: $972.27
• Consensus Rating: Moderate Buy

McKesson Stock Analysis - MarketRank™

McKesson scored higher than 99% of companies evaluated by MarketBeat, and ranked 11th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

McKesson has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on no strong buy ratings, 14 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

McKesson has a consensus price target of $972.27, representing about 27.1% upside from its current price of $764.77.

Amount of Analyst Coverage

McKesson has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 13.38%

Earnings Growth

Earnings for McKesson are expected to grow by 13.38% in the coming year, from $39.02 to $44.24 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of McKesson is 22.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.28.

Price to Earnings Ratio vs. Sector

The P/E ratio of McKesson is 22.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.02.

Price to Earnings Growth Ratio

McKesson has a PEG Ratio of 1.17. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.11% of the float of McKesson has been sold short.

Short Interest Ratio / Days to Cover

McKesson has a short interest ratio ("days to cover") of 3.84, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in McKesson has recently increased by 3.24%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

McKesson has a dividend yield of 0.41%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

McKesson has been increasing its dividend for 17 years.

Dividend Coverage

The dividend payout ratio of McKesson is 9.43%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, McKesson will have a dividend payout ratio of 7.41% next year. This indicates that McKesson will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 0.98

News Sentiment

McKesson has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 29 news articles for McKesson this week, compared to 9 articles on an average week.

Search Interest

43 people have searched for MCK on MarketBeat in the last 30 days. This is an increase of 169% compared to the previous 30 days.

MarketBeat Follows

18 people have added McKesson to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,518,555.00 in company stock.

Percentage Held by Insiders

0.08% of the stock of McKesson is held by insiders.

Percentage Held by Institutions

85.07% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MCK Stock Analysis - Frequently Asked Questions

How have MCK shares performed this year?

McKesson's stock was trading at $820.18 at the beginning of 2026. Since then, MCK stock has decreased by 6.8% and is now trading at $764.7650.

How were McKesson's earnings last quarter?

McKesson Corporation (NYSE:MCK) posted its quarterly earnings results on Wednesday, February, 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson's revenue for the quarter was up 11.4% compared to the same quarter last year.
Read the conference call transcript.

Does McKesson have any subsidiaries?

The following companies are subsidiaries of McKesson: Echo, LloydsDirect, Medical Specialties Distributors, Well.ca, RxCrossroads, CoverMyMeds, HealthQx, and others.

Who are McKesson's major shareholders?

McKesson's top institutional investors include Swedbank AB (0.82%), Bank of New York Mellon Corp (0.67%), Sumitomo Mitsui Trust Group Inc. (0.23%) and Principal Financial Group Inc. (0.22%). Insiders that own company stock include Britt J Vitalone, Nancy Avila, Brian S Tyler, Michele Lau, Leann B Smith, Thomas L Rodgers, Maria Martinez, Susan R Salka and Napoleon B Rutledge Jr.
View institutional ownership trends.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some other companies that McKesson investors own include Comcast (CMCSA), Chevron (CVX), Bristol Myers Squibb (BMY), Charles Schwab (SCHW), Edwards Lifesciences (EW), Yum! Brands (YUM) and Toronto Dominion Bank (TD).

Company Calendar

• Last Earnings: 2/04/2026
• Record date for 4/1 Dividend: 3/02/2026
• Ex-Dividend for 4/1 Dividend: 3/02/2026
• Dividend Payable: 4/01/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 5/07/2026
• Bank of America Global Healthcare Conference 2026: 5/12/2026
• Record date for 7/1 Dividend: 6/01/2026
• Ex-Dividend for 7/1 Dividend: 6/01/2026
• Dividend Payable: 7/01/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:MCK
• CIK: 927653
• Web: www.mckesson.com
• Phone: (972) 446-4800
• Fax: 415-983-8453
• Employees: 45,000
• Year Founded: 1833

Price Target and Rating

• Average Price Target for McKesson: $972.27
• High Price Target: $1,107.00
• Low Price Target: $856.00
• Potential Upside/Downside: +28.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.82
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): $34.77
• Trailing P/E Ratio: 21.79
• Forward P/E Ratio: 19.43
• P/E Growth: 1.17
• Net Income: $3.30 billion
• Net Margins: 1.09%
• Pretax Margin: 1.40%
• Return on Equity: -338.97%
• Return on Assets: 5.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.88
• Quick Ratio: 0.48

Sales & Book Value

• Annual Sales: $359.05 billion
• Price / Sales: 0.26
• Cash Flow: $36.47 per share
• Price / Cash Flow: 20.79
• Book Value: ($13.52) per share
• Price / Book: -56.07

Miscellaneous

• Outstanding Shares: 122,490,000
• Free Float: 122,389,000
• Market Cap: $92.86 billion
• Optionable: Optionable
• Beta: 0.35